Stay updated on Pembrolizumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Colorectal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry v3.4.3 was added to the history, and the previous entry v3.4.2 was removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedA new site revision label, Revision: v3.4.2, appears replacing the previous v3.4.1; this is a minor update with no changes to study data, statuses, or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1, with no visible changes to study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedUI updates add show/hide glossary controls and color-coded change highlights, along with a new revision label v3.4.0. These changes affect presentation on the record history page without altering study data or results.SummaryDifference0.7%

- Check60 days agoChange DetectedThe Record History page updates the revision from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check82 days agoChange DetectedAdministrative updates include a new site revision note (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure link, along with the deletion of Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Colorectal Cancer Clinical Trial page.